Importer of Controlled Substances Application: VHG Labs DBA LGC Standards, 10357-10358 [2021-03381]

Download as PDF 10357 Federal Register / Vol. 86, No. 32 / Friday, February 19, 2021 / Notices responsibility. See supra II.C; RD, at 21 (citing Arvinder Singh, M.D., 81 FR 8247, 8249–51 (2016)); Stein, 84 FR 46973. Additionally, Respondent plead nolo contendere instead of guilty to the charge of offering unlawful Medi-Cal remuneration. GX 3. ‘‘In general, however, a plea of nolo contendere is inconsistent with the acceptance of responsibility.’’ RD, at 21 (citing United States v. Gordon, 979 F. Supp. 337, 342 (E.D. Pa. 1997) (internal citations omitted)). Finding that a respondent has failed to accept responsibility is warranted where, as here, the respondent pled nolo contendere and minimized his role in the crime. See Jeffery M. Freesemann, M.D., 76 FR 60873, 60888 (2011); see also RD, at 22. Respondent must convince the Administrator that his acceptance of responsibility and remorse are sufficiently credible to demonstrate that the misconduct will not recur. Respondent, in his opening statement, argued that his testimony would show ‘‘his genuine remorse . . . .’’ Tr. 14. But the record indicates that Respondent was not remorseful for what he did; instead that he regretted the consequences that flowed from his conviction.14 Id. at 31, 39, 68. This lack of remorse goes hand-in-hand with Respondent’s failure to accept responsibility and further supports the revocation of his registration. In sanction determinations, the Agency has historically considered its interest in deterring similar acts, both with respect to the respondent in a particular case and the community of registrants. See Joseph Gaudio, M.D., 74 FR 10083, 10095 (2009); Singh, 81 FR at 8248. In this case, the Respondent knew at the time that he committed the crime that his actions were illegal—he even told Mr. Gonzales that the actions were illegal and advised him not to tell anyone. Deterring such deceit and knowing criminal behavior both in Respondent and the general registrant community is relevant to ensuring compliance with the CSA. Although I would not characterize Respondent’s underlying crime as particularly egregious, Respondent has not convinced me that he will not repeat such deceitful behavior in using his CSA registration. Respondent has argued, among other things, that he can be entrusted with a registration because he has seen over 15,000 patients in twenty years and has never had any issues with prescribing, he has never had a malpractice complaint, he is very mindful of the opioid crisis, and he has satisfied the terms of his probation. Tr. 13–14, 37, 74. Even assuming, arguendo, all of this to be true, Respondent needed to present evidence of a credible and persuasive acceptance of responsibility. Respondent has not. Based on Respondent’s failure to accept responsibility for his criminal misconduct and lack of demonstrated remorse, I cannot find that Respondent can be entrusted with a DEA registration; and therefore, I find that revocation is the appropriate sanction I will therefore order that Respondent’s registration be revoked as contained in the Order below. Order Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. BA6641472 issued to Ibrahim Al-Qawaqneh, D.D.S. This Order is effective March 22, 2021. D. Christopher Evans, Acting Administrator. ACTION: Notice of application. VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 22, 2021. Such persons may also file a written request for a hearing on the application on or before March 22, 2021. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on February 2, 2021, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchester, New Hampshire 03103, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: [FR Doc. 2021–03360 Filed 2–18–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–793] Importer of Controlled Substances Application: VHG Labs DBA LGC Standards Drug Enforcement Administration, Justice. AGENCY: tkelley on DSKBCP9HB2PROD with NOTICES Controlled substance Drug code Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. Naphyrone ....................................................................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................... SR-18 (Also known as RCS-–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ............................................... APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ................................................................................................... SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ...................................................................... 14 For example, Respondent testified ‘‘I really suffered going through these things—something I didn’t do . . . [I] lost most—most of my patients, VerDate Sep<11>2014 21:07 Feb 18, 2021 Jkt 253001 lost a lot of PPO insurances. I have to pay a lot of employees, and so many things for something that happened—someone faking like, you know, PO 00000 Frm 00125 Fmt 4703 Sfmt 4703 1235 1237 1258 1475 6250 7008 7048 7081 7104 Schedule I I I I I I I I I accusing you of doing something, but there’s no 100 percent proof.’’ Tr. 68. E:\FR\FM\19FEN1.SGM 19FEN1 10358 Federal Register / Vol. 86, No. 32 / Friday, February 19, 2021 / Notices Controlled substance Drug code tkelley on DSKBCP9HB2PROD with NOTICES JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...................................................................................................... UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... Ibogaine ........................................................................................................................................................................... Lysergic acid diethylamide .............................................................................................................................................. Marihuana Extract ........................................................................................................................................................... Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... Mescaline ......................................................................................................................................................................... JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ Psilocyn ........................................................................................................................................................................... 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... Codeine-N-oxide .............................................................................................................................................................. Desomorphine ................................................................................................................................................................. Dihydromorphine ............................................................................................................................................................. Heroin .............................................................................................................................................................................. Morphine-N-oxide ............................................................................................................................................................ Normorphine .................................................................................................................................................................... Tilidine ............................................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... Methamphetamine ........................................................................................................................................................... Phenmetrazine ................................................................................................................................................................. Methylphenidate .............................................................................................................................................................. Amobarbital ...................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Glutethimide ..................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... Norfentanyl ...................................................................................................................................................................... Phenylacetone ................................................................................................................................................................. Codeine ........................................................................................................................................................................... Dihydrocodeine ................................................................................................................................................................ Diphenoxylate .................................................................................................................................................................. Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. Hydrocodone ................................................................................................................................................................... Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Meperidine intermediate-B .............................................................................................................................................. Meperidine intermediate-C .............................................................................................................................................. Methadone intermediate .................................................................................................................................................. Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. Morphine .......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... 14-Hydroxmorphone ........................................................................................................................................................ Noroxymorphone ............................................................................................................................................................. Sufentanil ......................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s VerDate Sep<11>2014 21:07 Feb 18, 2021 Jkt 253001 business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2021–03381 Filed 2–18–21; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00126 Fmt 4703 Sfmt 4703 7118 7122 7144 7203 7260 7315 7350 7360 7370 7381 7398 7405 7431 7438 7498 7535 7540 7541 7542 9053 9055 9145 9200 9307 9313 9750 9814 9821 1105 1631 1724 2125 2270 2315 2550 7471 8333 8366 8501 9050 9120 9170 9180 9190 9193 9220 9230 9233 9234 9254 9273 9300 9333 9665 9668 9740 9801 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II II II NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice: (21–009)] NASA Astrophysics Advisory Committee; Meeting National Aeronautics and Space Administration. ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, Public SUMMARY: E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 86, Number 32 (Friday, February 19, 2021)]
[Notices]
[Pages 10357-10358]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03381]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-793]


Importer of Controlled Substances Application: VHG Labs DBA LGC 
Standards

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: VHG Labs DBA LGC Standards has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before March 22, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before March 22, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on February 2, 2021, VHG Labs DBA LGC Standards, 3 
Perimeter Road, Manchester, New Hampshire 03103, applied to be 
registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Cathinone................................            1235  I
Methcathinone............................            1237  I
Naphyrone................................            1258  I
N-Ethylamphetamine.......................            1475  I
JWH-250 (1-Pentyl-3-(2-                              6250  I
 methoxyphenylacetyl) indole).
SR-18 (Also known as RCS--8) (1-                     7008  I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole).
APINACA and AKB48 N-(1-Adamantyl)-1-                 7048  I
 pentyl-1H-indazole-3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4-                           7081  I
 methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3-             7104  I
 [(4-methoxy)-benzoyl] indole.

[[Page 10358]]

 
JWH-018 (also known as AM678) (1-Pentyl-3-           7118  I
 (1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-                     7122  I
 naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-             7144  I
 tetramethylcyclopropyl)methanone.
JWH-203 (1-Pentyl-3-(2-                              7203  I
 chlorophenylacetyl) indole).
Ibogaine.................................            7260  I
Lysergic acid diethylamide...............            7315  I
Marihuana Extract........................            7350  I
Marihuana................................            7360  I
Tetrahydrocannabinols....................            7370  I
Mescaline................................            7381  I
JWH-398 (1-Pentyl-3-(4-chloro-1-                     7398  I
 naphthoyl) indole).
3,4-Methylenedioxymethamphetamine........            7405  I
5-Methoxy-N-N-dimethyltryptamine.........            7431  I
Psilocyn.................................            7438  I
4-Methyl-alphapyrrolidinopropiophenone (4-           7498  I
 MePPP).
MDPV (3,4-Methylenedioxypyrovalerone)....            7535  I
Methylone (3,4-Methylenedioxy-N-                     7540  I
 methylcathinone).
Butylone.................................            7541  I
Pentylone................................            7542  I
Codeine-N-oxide..........................            9053  I
Desomorphine.............................            9055  I
Dihydromorphine..........................            9145  I
Heroin...................................            9200  I
Morphine-N-oxide.........................            9307  I
Normorphine..............................            9313  I
Tilidine.................................            9750  I
Alpha-methylfentanyl.....................            9814  I
Acetyl Fentanyl (N-(1-phenethylpiperidin-            9821  I
 4-yl)-N-phenylacetamide).
Methamphetamine..........................            1105  II
Phenmetrazine............................            1631  II
Methylphenidate..........................            1724  II
Amobarbital..............................            2125  II
Pentobarbital............................            2270  II
Secobarbital.............................            2315  II
Glutethimide.............................            2550  II
Phencyclidine............................            7471  II
4-Anilino-N-phenethyl-4-piperidine (ANPP)            8333  II
Norfentanyl..............................            8366  II
Phenylacetone............................            8501  II
Codeine..................................            9050  II
Dihydrocodeine...........................            9120  II
Diphenoxylate............................            9170  II
Ecgonine.................................            9180  II
Ethylmorphine............................            9190  II
Hydrocodone..............................            9193  II
Levorphanol..............................            9220  II
Meperidine...............................            9230  II
Meperidine intermediate-B................            9233  II
Meperidine intermediate-C................            9234  II
Methadone intermediate...................            9254  II
Dextropropoxyphene, bulk (non-dosage                 9273  II
 forms).
Morphine.................................            9300  II
Thebaine.................................            9333  II
14-Hydroxmorphone........................            9665  II
Noroxymorphone...........................            9668  II
Sufentanil...............................            9740  II
Fentanyl.................................            9801  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis. In reference 
to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the 
company plans to import a synthetic cannabidiol and a synthetic 
tetrahydrocannabinol. No other activities for these drug codes are 
authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03381 Filed 2-18-21; 8:45 am]
BILLING CODE 4410-09-P